BFRI - Biofrontera Inc. Stock Price, Fair Value and News

$0.98-0.04 (-3.92%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

BFRI Price Action

Last 7 days

-7.5%

Last 30 days

25.6%

Last 90 days

-23.4%

Trailing 12 Months

-69.7%

BFRI RSI Chart

BFRI Valuation

Market Cap

7.6M

Price/Earnings (Trailing)

-0.59

Price/Sales (Trailing)

0.22

EV/EBITDA

-0.42

Price/Free Cashflow

-0.42

BFRI Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

BFRI Fundamentals

BFRI Revenue

Revenue (TTM)

35.2M

Rev. Growth (Yr)

34.05%

Rev. Growth (Qtr)

-0.92%

BFRI Earnings

Earnings (TTM)

-12.8M

Earnings Growth (Yr)

10.61%

Earnings Growth (Qtr)

-2.1K%

BFRI Profitability

EBT Margin

-36.38%

Return on Equity

-232.13%

Return on Assets

-69.33%

Free Cashflow Yield

-238.65%

BFRI Investor Care

Shares Dilution (1Y)

410.61%

Diluted EPS (TTM)

0.59

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	33.3M	35.2M	0	0
2023	27.7M	29.0M	33.6M	34.1M
2022	29.1M	27.7M	27.7M	28.7M
2021	20.2M	21.5M	22.8M	24.1M
2020	0	0	22.5M	18.8M
2019	0	0	0	26.2M

Get all data in R, Python etc through our Historical Stock Data APIs

About Biofrontera Inc.

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription drug for the treatment of impetigo. The company was founded in 1997 and is headquartered in Woburn, Massachusetts.

CEO	Dr. Hermann Luebbert Ph.D.
WEBSITE	biofrontera-us.com
SECTOR	Healthcare
INDUSTRY	Drug Manufacturers Specialty & Generic
EMPLOYEES	81

Biofrontera Inc. Frequently Asked Questions

What is the ticker symbol for Biofrontera Inc.? What does BFRI stand for in stocks?

BFRI is the stock ticker symbol of Biofrontera Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Biofrontera Inc. (BFRI)?

As of Fri Dec 20 2024, market cap of Biofrontera Inc. is 7.59 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BFRI stock?

You can check BFRI's fair value in chart for subscribers.

Is Biofrontera Inc. a good stock to buy?

The fair value guage provides a quick view whether BFRI is over valued or under valued. Whether Biofrontera Inc. is cheap or expensive depends on the assumptions which impact Biofrontera Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BFRI.

What is Biofrontera Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, BFRI's PE ratio (Price to Earnings) is -0.59 and Price to Sales (PS) ratio is 0.22. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BFRI PE ratio will change depending on the future growth rate expectations of investors.